BridgeMD
New treatment option for Hemodialysis
Official title Prophylactic Antibiotic Treatment in Hemodialysis
ClinicalTrials.gov ID: NCT05248620
What this study is testing
- What it's testing
- The purpose of this study is to assess the efficacy of prophylactic antibiotic treatment on blood stream infections and severe culture negative infections, in patients on newly started hemodialysis(HD), with a central venous catheter as vascular access.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- End Stage Kidney Disease (ESKD) patients who receive an uncuffed or cuffed CVC for expected chronic HD, regardless of previous ESKD treatment...
- ≥18 years
- Ability to understand the study background, risk and benefit of treatment and to give written informed consent
You likely can't join if
- Unable to give informed consent
- Known intolerance to beta-lactam antibiotics and clindamycin
- Active infection treated with antibiotics
- Breastfeeding
- Pregnancy. In women of childbearing age, an approved birth control must be ensured at least 1 month before and during all the 6 months of...
The study team makes the final eligibility decision.
Where it's taking place
- Copenhagen, Capital Region, Denmark
- Hillerød, Capital Region, Denmark
- Aarhus, Middle Region, Denmark
- Aalborg, North Region, Denmark
- Roskilde, Region Sjælland, Denmark
- Odense, Region South, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Copenhagen, Capital Region, Denmark; Hillerød, Capital Region, Denmark; Aarhus, Middle Region, Denmark; Aalborg, North Region, Denmark; Roskilde, Region Sjælland, Denmark; Odense, Region South, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.